FLT3 and acute myeloid leukemia: While patients with AML with FLT3-ITD generally achieve remission with chemotherapy, they relapse rapidly [1] and AML cells frequently have new structural chromosome abnormalities at relapse [4], consistent with a role of genomic instability in FLT3-ITD AML progression and relapse.